Treatment with the broad-spectrum MMP inhibitor GM6001 significantly reduced invasiveness of stable GDF15-overexpressing clones (Figure 5B), suggesting that MMPs contribute to the invasive phenotype of GDF15-overexpressing breast cancer cells. This evidence concerns the gene GDF15 and breast carcinoma.